• Home
  • >
  • Iol Chemicals Pharmaceuticals Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/iol-chemicals-pharmaceuticals-ltd.png Logo

Iol Chemicals Pharmaceuticals Ltd Financial Statement

Iol Chemicals Pharmaceuticals Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue511.44528.77552.41
Operating Expense453.84475.91481.2
Net Profit28.1923.2337.79
Net Profit Margin5.514.396.84
Earning Per Share4.83.966.44
EBIDTA53.0450.1369.01
Effective Tax Rate8.7211.8815.6

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Iol Chemicals Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022
Total Revenue Annual2,217.112,184.02
Operating Expenses Annual1,991.441,925.73
Operating Profit Annual251.28276.4
Interest Annual16.478.29
Depreciation46.1643.26
Net Profit Annual139.14167.67
Tax Annual49.5157.18

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Iol Chemicals Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022
Cash Flow at the Beginning3.2332.34
Cash Flow from Operations122.2793.05
Cash Flow from Investing-120-120.52
Cash Flow from Financing-4.11-1.64
Cash Flow at the End1.393.23

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Iol Chemicals Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022
PBDIT Margin (%)11.3312.66
PBIT Margin (%)9.2510.67
PBT Margin (%)8.699.38
Net PROFIT Margin (%)6.317.59
Return On Networth / Equity (%)9.612.04
Return On Networth /Employed(%)13.5416.2
Return On Assets (%)9.2211.53
Total Debt / Equity(X)0.040.02
Asset Turnover Ratio (%)1.461.52

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Iol Chemicals Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022
Fixed Assets Annual760.05563.81
Total Current Assets Annual920.391,080.82
Non Current Assets Annual1,101.74881.48
Total Shareholders Funds Annual1,507.721,392.28
Total Assets Annual2,022.131,962.3

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Iol Chemicals Pharmaceuticals Ltd Earning Calls
Mar 2024
EPS beaten by 0.21 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Iol Chemicals Pharmaceuticals Ltd has a market capitalization of 2,122.2 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Iol Chemicals Pharmaceuticals Ltd is debt-free with a debt-to-equity ratio of 0.02.

In FY 2023, Iol Chemicals Pharmaceuticals Ltd recorded a total revenue of approximately 2,132.79 Cr marking a significant milestone in the company's financial performance.

Iol Chemicals Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and -0.0% annually, respectively..

Iol Chemicals Pharmaceuticals Ltd's current PE ratio is 15.79.

Iol Chemicals Pharmaceuticals Ltd's ROCE averaged 13.7% from the FY ending March 2022 to 2024, with a median of 12.9%. It peaked at 16.2% in March 2022, reflecting strong capital efficiency over the period..

Iol Chemicals Pharmaceuticals Ltd's latest EBIT is Rs. 197.75 Cr, surpassing the average EBIT of Rs. 212 Cr over the 5 years..